Byung-Ki Cho

Chief Executive Officer at BIONOTE, INC.

Net worth: 1 M $ as of 2024-04-29

56 year

Health Technology

Profile

Byung-Ki Cho is currently the Chief Executive Officer & Director at BioNote, Inc. He previously worked as the Director & Head-Research Center at Abbott Diagnostics Korea, Inc.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SD BIOSENSOR, INC. 0.12%	2024-03-27	150,000 ( 0.12% )	1 M $	2024-04-29

Byung-Ki Cho active positions

Companies	Position	Start
BIONOTE, INC.	Chief Executive Officer	2020-07-31

All active positions of Byung-Ki Cho

Former positions of Byung-Ki Cho

Companies	Position	End
Abbott Diagnostics Korea, Inc. Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea.	Chief Executive Officer	-

See the detail of Byung-Ki Cho's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Byung-Ki Cho's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BIONOTE, INC.	Health Technology

Private companies	1
Abbott Diagnostics Korea, Inc. Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea.	Health Technology